Co-Authors
This is a "connection" page, showing publications co-authored by Paolo Brambilla and Silvia Piantoni.
Connection Strength
1.199
-
Reports of three long-term lung disease following SARS-CoV-2 infection. J Med Virol. 2021 May; 93(5):2585-2587.
Score: 0.464
-
Response to: 'Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'' by Kawada. Ann Rheum Dis. 2021 Jan 27.
Score: 0.232
-
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al. Ann Rheum Dis. 2020 Aug 27.
Score: 0.225
-
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al. Clin Rheumatol. 2020 08; 39(8):2489-2490.
Score: 0.222
-
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome. Ann Rheum Dis. 2020 10; 79(10):1286-1289.
Score: 0.056